Functional genomic screens and identification of signaling pathways in oxaliplatin-resistance in colorectal cancer.

被引：0
|
作者：
Mettu, Niharika B.
Uronis, Joshua M.
Osada, Takuya
Lu, Min
Osada, Koya
Mook, Robert
Chen, Wei
Morse, Michael
Lyerly, H. Kim
Wood, Kris
Hsu, Shiaowen David
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Univ, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.3611
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3611
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Isolinderalactone sensitizes oxaliplatin-resistance colorectal cancer cells through JNK/p38 MAPK signaling pathways
    Kwak, Ah-Won
    Park, Jin Woo
    Lee, Seung-On
    Lee, Jin-Young
    Seo, Ji-hye
    Yoon, Goo
    Lee, Mee-Hyun
    Choi, Joon-Seok
    Shim, Jung-Hyun
    PHYTOMEDICINE, 2022, 105
  • [2] A functional genomics approach to the identification of genes involved in resistance to Oxaliplatin in colorectal cancer
    Invrea, Federica
    Cavicchioli, Francesca
    Petti, Consalvo
    Russo, Rosalia
    Isella, Claudio
    Medico, Enzo
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Pathways of oxaliplatin/5-fluorouracil resistance in colorectal cancer
    Turkington, R.
    Allen, W.
    Stevenson, L.
    Coyle, V.
    Jithesh, P.
    Proutski, I.
    Fenning, C.
    Stewart, G.
    Longley, D.
    Johnston, P.
    EJC SUPPLEMENTS, 2009, 7 (02): : 342 - 342
  • [4] circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637
    Zhang, Yanli
    Li, Chen
    Liu, Xinfeng
    Wang, Yanlei
    Zhao, Rui
    Yang, Yongmei
    Zheng, Xin
    Zhang, Yi
    Zhang, Xin
    EBIOMEDICINE, 2019, 48 : 277 - 288
  • [5] Functional interference screens targeting signaling components in colorectal cancer cells
    Klatz-Noack, K.
    Klinger, B.
    Bluethgen, N.
    Schaefer, R.
    Sers, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 76 - 76
  • [6] Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells
    Lu, Wei-Qun
    Hu, Ying-Ying
    Lin, Xiao-Ping
    Fan, Wei
    ONCOTARGET, 2017, 8 (27) : 44171 - 44185
  • [7] Genomic profiles of BRAF inhibitor resistance mechanisms in metastatic colorectal cancer.
    Xu, Ting
    Wang, Xicheng
    Qi Changsong
    Wang, Zhenghang
    Li, Jian
    Shen, Lin
    Wang, Jia
    Lin, Xuan
    Zhang, Lu
    Lin, Jing
    Li, Xi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Drug repositioning by in vivo functional genomic screens using PDX models in colorectal cancer
    Inoue, Akira
    Carugo, Alessandro
    Bristow, Christopher
    Hara, Joji
    Murata, Masaru
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    Kopetz, Scott
    Draetta, Giulio F.
    CANCER SCIENCE, 2018, 109 : 233 - 233
  • [9] Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer
    Misbah, Md
    Kumar, Manoj
    Lee, Kuen-Huar
    Shen, Shing-Chuan
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [10] Identification of Genome Maintenance Proteins with Functional Genomic Screens
    Cortez, David
    FASEB JOURNAL, 2010, 24
12345